Comparative Evaluation of Growth Factor Bioavailability–Enhanced Allograft Vs Autogenous Bone Graft in Anterior Maxillary Ridge Augmentation - Takeaways - DentalSpire

Comparative Evaluation of Growth Factor Bioavailability–Enhanced Allograft Vs Autogenous Bone Graft in Anterior Maxillary Ridge Augmentation

  • By

  • Ren Chang, DDS

  • July 1, 2026

  • 10 min

Share

  • 1

    Alveolar ridge deficiencies can hinder implant placement in the anterior maxilla, necessitating augmentation procedures.

  • 2

    A growth factor bioavailability–enhanced allograft (GFBA) was compared to autogenous bone graft in a case of ridge augmentation.

  • 3

    At 11 months, both GFBA and autogenous graft sites showed successful ridge augmentation and stable peri-implant bone levels.

  • 4

    The GFBA site exhibited a homogeneous trabecular pattern and advanced integration, while the autogenous graft showed ongoing remodeling.

  • 5

    GFBA may serve as a viable alternative to autogenous bone grafting for moderate ridge defects in implant dentistry.

Original Source(s)

Related Content